Zobrazeno 1 - 10
of 31
pro vyhledávání: '"59"'
Autor:
Andrea Browatzki, Helene Priemé, Therese S. Lapperre, Oliver Djurhuus Tupper, Pradeesh Sivapalan, Ida Steffensen, Christian Søborg, Casper Tidemandsen, Tor Biering-Sørensen, Dorthe Høgsberg, Jens-Ulrik Stæhr Jensen, Muhzda Ghanizada, Daniel Bech Rasmussen, Peter Lange, Uffe Bodtger, Asger Sverrild, Vibeke Gottlieb, Christina Marisa Bergsoe, Sidse Graff Jensen, Josefin Eklöf, Jens D Lundgren, Tobias Wirenfeldt Klausen, Martin Steen Frydland, Eva Brøndum, Alexander Jordan, Kjell Erik Julius Håkansson, Lars Egholm Pedersen, Charlotte Suppli Ulrik, Jon Torgny Wilcke, Howraman Meteran, Rasmus Dahlin Bojesen, Filip K. Knop
Publikováno v:
The European Respiratory Journal
article-version (AM) Accepted Manuscript
Sivapalan, P, Suppli Ulrik, C, Sophie Lapperre, T, Dahlin Bojesen, R, Eklöf, J, Browatzki, A, Torgny Wilcke, J, Gottlieb, V, Julius Håkansson, K E, Tidemandsen, C, Tupper, O, Meteran, H, Bergsøe, C, Brøndum, E, Bodtger, U, Bech Rasmussen, D, Graff Jensen, S, Pedersen, L, Jordan, A, Priemé, H, Søborg, C, Steffensen, I E, Høgsberg, D, Wirenfeldt Klausen, T, Steen Frydland, M, Lange, P, Sverrild, A, Ghanizada, M, Krag Knop, F, Biering-Sørensen, T, Lundgren, J D, Stæhr Jensen, J-U & ProPAC-COVID study group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Sivapalan, P & ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
article-version (AM) Accepted Manuscript
Sivapalan, P, Suppli Ulrik, C, Sophie Lapperre, T, Dahlin Bojesen, R, Eklöf, J, Browatzki, A, Torgny Wilcke, J, Gottlieb, V, Julius Håkansson, K E, Tidemandsen, C, Tupper, O, Meteran, H, Bergsøe, C, Brøndum, E, Bodtger, U, Bech Rasmussen, D, Graff Jensen, S, Pedersen, L, Jordan, A, Priemé, H, Søborg, C, Steffensen, I E, Høgsberg, D, Wirenfeldt Klausen, T, Steen Frydland, M, Lange, P, Sverrild, A, Ghanizada, M, Krag Knop, F, Biering-Sørensen, T, Lundgren, J D, Stæhr Jensen, J-U & ProPAC-COVID study group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Sivapalan, P & ProPAC-COVID writing group on behalf of the ProPAC-COVID Study Group 2022, ' Azithromycin and hydroxychloroquine in hospitalised patients with confirmed COVID-19 : a randomised double-blinded placebo-controlled trial ', European Respiratory Journal, vol. 59, no. 1, 2100752 . https://doi.org/10.1183/13993003.00752-2021
Background Combining the antibiotic azithromycin and hydroxychloroquine induces airway immunomodulatory effects, with the latter also having in vitro antiviral properties. This may improve outcomes in patients hospitalised for COVID-19. Methods Place
Publikováno v:
Idiopathic interstitial pneumonias.
Background: Idiopathic pulmonary fibrosis (IPF) is fatal, progressive fibrosing, lung disease of unknown cause. Anti-fibrotic drugs can slow down the progression of the disease and reduce mortality. However, discontinuation rates of 19-21% have been
Autor:
Wim A. Wuyts, Matthijs F.M. van Oosterhout, Ivo A. Wiertz, Jan C. Grutters, Coline H.M. van Moorsel, Wouter van Es, Miranda Ten Hoedt-Zijp, Renske Vorselaars
Publikováno v:
1.5 Diffuse Parenchymal Lung Disease.
Background The diagnostic classification “possible idiopathic pulmonary fibrosis (IPF)” is characterised by an inconsistent usual interstitial pneumonia (UIP) pattern on HRCT-scan and a UIP pattern in surgical lung biopsy. Therapeutic management
Autor:
Louise Dunn, Kirsty Honeyford, Liam G Heaney, Claire A. Butler, Yuqing Zhang, R Jayne Logan, P Jane McDowell, John H. Stone, Lorcan McGarvey
Publikováno v:
The European Respiratory Journal
article-version (VoR) Version of Record
McDowell, P J, Stone, J H, Zhang, Y, Honeyford, K, Dunn, L, Logan, R J, McGarvey, L P A, Butler, C A & Heaney, L G 2022, ' Glucocorticoid toxicity reduction with Mepolizumab using the glucocorticoid toxicity index ', European Respiratory Journal, vol. 59, no. 1 . https://doi.org/10.1183/13993003.00160-2021
article-version (VoR) Version of Record
McDowell, P J, Stone, J H, Zhang, Y, Honeyford, K, Dunn, L, Logan, R J, McGarvey, L P A, Butler, C A & Heaney, L G 2022, ' Glucocorticoid toxicity reduction with Mepolizumab using the glucocorticoid toxicity index ', European Respiratory Journal, vol. 59, no. 1 . https://doi.org/10.1183/13993003.00160-2021
Background Reduction in glucocorticoid exposure is the primary benefit of new biologic treatments in severe asthma, but there is currently no evidence that reduction in glucocorticoid exposure corresponds to a proportionate reduction in associated to
Autor:
Inês Franco, Bruno Cabrita, Ivone Pascoal, Eduarda M. Tinoco, Inês Ladeira, Sara Martins, Ricardo Lima, Daniela Machado, Salete Valente
Publikováno v:
Airway pharmacology and treatment.
Background: Nasal polyposis may impact asthma severity and is a frequent comorbidity in patients with severe eosinophilic asthma. Research has suggested mepolizumab may directly affect upper airway type 2 inflammatory conditions, however there is a l
Autor:
Raffaele Scala, Uberto Maccari, Lucia Nardelli, Rosalba Maffucci, Carmela Martinez, Andrea Bianco
Publikováno v:
Interventional pulmonology.
Few data are available about feasibility of propofol sedation administered by pulmonologists.Compared to midazolam, propofol analgosedation is targeted to achieve deeper sedation with shorter recovery time; for safety, it is usually provided only by
Autor:
Girolamo Pelaia, Nicola Scichilone, Emanuela Resta, Cecilia Calabrese, Maria D'Amato, Nunzio Crimi, Maria Pia Foschino Barbaro, Corrado Pelaia, Onofrio Resta, Giulia Scioscia, Giovanna Elisiana Carpagnano
Publikováno v:
Ethics and economics.
Background: Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ quality of life and increased healthcare spending. Objectives: To assess the clinical and economic impact of switching from
Autor:
Silvia Pascual Erquicia, Javier Domínguez Ortega, Gustavo Resler, Xavier Muñoz Gall, Cecilia Jacqueline Martin Panadero, Gema Monteagudo Ruiz, Carlos Cabrera López
Publikováno v:
Airway pharmacology and treatment.
Background: Severe asthma treatment with oral corticosteroids (OCS) added to ICS-LABA combination, may imply poor control, elevated disease burden and increased adverse reactions Aims: Describe the medical burden in patients with severe uncontrolled
Autor:
Stefan Fischer, A Akil, Michael Semik, Nicolas Dickgreber, Deborrah Wehde, Mehyar Lavae-Mokhtari
Publikováno v:
Lung cancer.
Introduction: Small cell lung cancer makes up about 15 percent of all lung cancers. Extensive stage small cell lung cancer (ES-SCLC) carries a poor prognosis, and the thoracic progression is common. It is usually an aggressive cancer that tends to gr
Autor:
Giampietro Marchetti, Massimiliano Sivori, Alice Bragantini, Valentina Pinelli, Federica Novelli, Vanna Balestracci, Pier Aldo Canessa
Publikováno v:
Interventional pulmonology.
Background: TTP is one of the most effective pleurodesis methods in MPE but its optimal timing is not well-defined. While some groups perform thoracoscopic pleurodesis on the basis of endoscopic malignancy appearance during diagnostic medical thoraco